Key result
Cytosolic-exposed cardiolipin regulates cell death and immune proteins via chain saturation and oxidation.
This review highlights the structural and functional role of cardiolipin in regulating cell death and immune signaling, as well as its potential as a therapeutic target in related human diseases.
May support cardiolipin-targeted therapies in inflammatory diseases; leaves open clinical validation in prospective trials.
Cardiolipin (CL) is a tetra-acylated diphosphatidylglycerol lipid. In physiological conditions, CL presents unsaturated chains and is located in the inner mitochondria membrane (IMM). Dead signals, infection, or disease may change the level of CL saturation and oxidation and cause its translocation to the cytosolic side of the outer mitochondrial membrane (OMM), affecting mitochondrial function and the inflammatory response. In this review, we summarize the emerging proapoptotic, pro-, and anti-inflammatory functions of cytosolic-exposed CL and how they are regulated by CL chain saturation and oxidation. We underline how the unique dimeric phospholipid structure confers peculiar properties on CL in the regulation of cell death and immune system proteins, such as the Nucleotide-binding domain and leucine-rich repeat-containing pyrin protein 3 (NLRP3), caspases (Casp), and Toll-like receptor 4 (TLR4). We also provide an overview of the human diseases in which CL deficiency or modification are implicated and of the use of exogenous unsaturated CL (uCL) as a novel therapeutic approach.
No takes yet. Share an insight, caveat, or question.
Pizzuto et al. (2020) conducted a review in Cardiolipin deficiency or modification related diseases. Cardiolipin was evaluated. Cytosolic-exposed cardiolipin regulates cell death and immune system proteins, with its chain saturation and oxidation influencing pro- and anti-inflammatory functions.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: